Sex as an independent prognostic factor in a population-based, non-small cell lung cancer cohort

Canadian Respiratory Journal

Volumn 20, Issue 1, 2013, Pages 30-34

  Pitz, Marshall W ^a,b   Musto, Grace ^b   Navaratnam, Srisala ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

Author keywords

Adenocarcinoma; Non small cell; Sex; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SEX;

EID: 84876209593     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/618691     Document Type: Article

References (32)

1. Canadian Cancer Statistics 2011 (Accessed May 30, 2011).
2. Thomas L, Doyle L, Edelman M. Lung cancer in women: Emerging differences in epidemiology, biology, and therapy. Chest 2005;128:370-81.
3. Gasperino J, Rom W. Gender and lung cancer. Clin Lung Cancer 2004;5:353-9.
4. Patel J. Lung cancer in women. J Clin Oncol 2005;23:3212-8.
5. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines, 2nd edn. Chest 2007/9;132(3 Suppl):29S-55S.
6. Batevik R, Grong K, Segadal L, Stangeland L. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: A study of absolute and relative survival over 15 years. Lung Cancer 2005;47:173-81.
7. Caldarella A, Crocetti E, Comin CE, Janni A, Pegna AL, Paci E. Gender differences in non-small cell lung cancer: A populationbased study. Eur J Surg Oncol 2007;33:763-8.
8. Holmberg L, Sandin F, Bray FI, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: Differences occur early in follow-up. Thorax 2010;65:436-41.
9. Bernal M, Gomez F, Gomez G. Trends in cancer mortality in Spain: 1975-2004. Tumori 2009;95:669-74.
10. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13:1087-93.
11. Ferguson M, Skosey C, Hoffman P, Golomb H. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990;8:1402-7.
12. Wheatley-Price P, Ma C, Ashcroft L, et al. The strength of female sex as a prognostic factor in small-cell lung cancer: A pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit. Ann Oncol 2010;21:232-7.
13. Mostertz W, Stevenson M, Acharya C, et al. Age-and sex-specific genomic profiles in non-small cell lung cancer. JAMA 2010;303:535-3.
14. Cerfolio R, Bryant A, Scott E, et al. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest 2006;130:1796-802.
15. Chang J, Asamura H, Kawachi R, Watanabe S. Gender difference in survival of resected non-small cell lung cancer: Histology-related phenomenon? J Thorac Cardiovasc Surg 2009;137:807-12.
16. Wheatley-Price P, Blackhall F, Lee S, et al. The influence of sex and histology on outcomes in non-small-cell lung cancer: A pooled analysis of five randomized trials. Ann Oncol 2010;21:2023-8.
17. Wheatley-Price P, Le Maitre A, Ding K, et al Group NCT. The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials. J Thorac Oncol 2010;5:640-8.
18. Shepherd FA, Rodrigues Pereira J, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32.
19. Toyooka S, Takano T, Kosaka T, et al. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitnib-treated patients with lung adenocarcinoma. Cancer Sci 2008;99:303-8.
20. Pitz MW, Musto G, Demers AA, Kliewer EV, Navaratnam S. Survival and treatment pattern of non-small cell lung cancer over 20 years. J Thorac Oncol 2009;4:492-8.
21. Roos N, Shapiro E. Health and health care: Experience with a population-based health information system. Medical Care 1999;33(12 Suppl):DS1-DS146.
22. Chen VW, Wu XC. Incidence, Cancer in North America, 1991-1995. Sacramento: North America Association of Central Cancer Registries (NAACCR); 1999.
23. Diggle P, Heagerty P, Liang K, Zeger S. Analysis of Longitudinal Data, 2nd edn. Oxford: Oxford University Press; 2002.
24. Ying Z, Jung SH, Wei LJ. Survival analysis with median regression models. J Am Statist Assoc 1995;90:178-84.
25. Stata C: Stata Statistical Software, 10 edn. College Station: Stata Corporation; 2007.
26. Albain KS, Unger J, Gotay C, et al. Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials. J Clin Oncol 2007;25(Suppl 18).
27. Efficace F, Bottomley A, Smit E, et al. Is a patient's self-reported health-related quality of life a prognostic factor for survival in nonsmall-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006;17:1698-704.
28. Wakelee HA, Wang W, Schiller JH et al; for the Eastern Cooperative Oncology Group. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol 2006;1:441-6.
29. Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group Data. J Clin Oncol 2005;23:175-83.
30. Visbal AL, Williams BA, Nichols FC III, et al. Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-15.
31. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. J Clini Oncol 1991;9:1618-26.
32. Planchard D, Loriot Y, Goubar A, Commo Fd, Soria J-C. Differential expression of biomarkers in men and women. Semin Oncol 2009;36:553-65.